Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Alabama at Birmingham, Moffitt Cancer Center, University of North Carolina at Chapel Hill, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Harvard University, Massachusetts General Hospital, University of Colorado Denver, The Ohio State University Wexner Medical Center, University of Southern California, USC Norris Comprehensive Cancer Center, Pfizer (United States), University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2806201321